Home > Healthcare > Analytical Instruments > Molecular Analysis > microarray scanners market
Get a free sample of Microarray Scanners Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Microarray Scanners Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The microarray scanners industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive scanners with improved efficiency and affordability. This includes advancements in design, precision, automation, and customization. Competition is driven by factors such as the quality, reliability, and ease of usage along with integration capabilities with existing technologies, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.
Some of the eminent market participants operating in the microarray scanners industry include:
The fluorescence segment in the microarray scanners market will generate USD 806 million by 2032, backed by the high sensitivity and specificity, allowing accurate detection and quantification of fluorescently labeled molecules on microarrays.
Microarray scanners market size was valued at USD 939.4 million in 2023 and is estimated to grow at 8.2% CAGR from 2024 to 2032, owing to the growing technological advancements.
Agilent Technologies, Inc., Arrayit Corporation, Aushon BioSystems, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Hitachi High-Tech Corporation, Illumina, Inc., LI-COR Biosciences, Microarrays, Inc., Oxford Gene Technology, and PerkinElmer, Inc.
U.S. microarray scanners market size is anticipated to grow at 7.9% CAGR during 2024-2032, attributed to the high prevalence of chronic diseases, including cancer, diabetes, and hypertension.